Paul L. Herrling

2.2k total citations
43 papers, 1.6k citations indexed

About

Paul L. Herrling is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Economics and Econometrics. According to data from OpenAlex, Paul L. Herrling has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 8 papers in Economics and Econometrics. Recurrent topics in Paul L. Herrling's work include Neuroscience and Neuropharmacology Research (11 papers), Ion channel regulation and function (7 papers) and Pharmaceutical Economics and Policy (7 papers). Paul L. Herrling is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Ion channel regulation and function (7 papers) and Pharmaceutical Economics and Policy (7 papers). Paul L. Herrling collaborates with scholars based in Switzerland, Cameroon and Japan. Paul L. Herrling's co-authors include C.D. Hull, Henry J. Olverman, Richard Morris, T.E. Salt, Richard H. Evans, J. Davies, Alan Wayne Jones, J.C. Watkins, Peter C.K. Pook and Elisabeth Ngo Bum and has published in prestigious journals such as Nature, The Journal of Physiology and Nature Reviews Drug Discovery.

In The Last Decade

Paul L. Herrling

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul L. Herrling Switzerland 19 972 676 263 156 151 43 1.6k
C. Portet Switzerland 11 735 0.8× 489 0.7× 132 0.5× 101 0.6× 121 0.8× 14 1.2k
Guo-Zhang Jin China 26 1.1k 1.1× 933 1.4× 198 0.8× 174 1.1× 63 0.4× 101 1.9k
H.‐R. Olpe Switzerland 12 573 0.6× 352 0.5× 117 0.4× 145 0.9× 114 0.8× 16 1.1k
Julianna Kardos Hungary 22 1.3k 1.4× 1.1k 1.6× 318 1.2× 102 0.7× 103 0.7× 117 2.3k
Timothy T. Soncrant United States 25 525 0.5× 436 0.6× 183 0.7× 213 1.4× 62 0.4× 52 1.5k
Porntip Supavilai Thailand 24 1.0k 1.0× 844 1.2× 123 0.5× 105 0.7× 83 0.5× 43 1.5k
H. Prast Austria 26 804 0.8× 887 1.3× 270 1.0× 113 0.7× 87 0.6× 67 2.5k
Stefania Ruiu Italy 21 551 0.6× 337 0.5× 106 0.4× 137 0.9× 118 0.8× 61 1.2k
Young Hoon Kim South Korea 27 530 0.5× 749 1.1× 148 0.6× 105 0.7× 70 0.5× 65 1.8k
Markus Schmutz Switzerland 26 1.8k 1.9× 1.1k 1.6× 358 1.4× 236 1.5× 167 1.1× 53 2.7k

Countries citing papers authored by Paul L. Herrling

Since Specialization
Citations

This map shows the geographic impact of Paul L. Herrling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Herrling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Herrling more than expected).

Fields of papers citing papers by Paul L. Herrling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul L. Herrling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Herrling. The network helps show where Paul L. Herrling may publish in the future.

Co-authorship network of co-authors of Paul L. Herrling

This figure shows the co-authorship network connecting the top 25 collaborators of Paul L. Herrling. A scholar is included among the top collaborators of Paul L. Herrling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul L. Herrling. Paul L. Herrling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacmin, Maxime, Emerson Ferreira Queiroz, Laurence Marcourt, et al.. (2020). Zebrafish bioassay-guided isolation of antiseizure compounds from the Cameroonian medicinal plant Cyperus articulatus L. Phytomedicine. 70. 153175–153175. 22 indexed citations
2.
Eder, Jörg & Paul L. Herrling. (2015). Trends in Modern Drug Discovery. Handbook of experimental pharmacology. 232. 3–22. 29 indexed citations
3.
Herrling, Paul L., et al.. (2010). List of Drugs in Development for Neurodegenerative Diseases: Update June 2010. Neurodegenerative Diseases. 8(1-2). 44–94. 6 indexed citations
4.
Herrling, Paul L.. (2009). Financing R&D for neglected diseases. Nature Reviews Drug Discovery. 8(2). 91–91. 11 indexed citations
5.
Pogačić, Vanda & Paul L. Herrling. (2008). List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases. 6(1-2). 37–86. 2 indexed citations
6.
Herrling, Paul L., et al.. (2006). List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases. 3(3). 148–186. 5 indexed citations
7.
Herrling, Paul L., et al.. (2005). List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases. 2(2). 61–108. 4 indexed citations
8.
Herrling, Paul L., Markus Rudin, & Alex Matter. (2005). Imaging in Drug Discovery and Early Clinical Trials. Birkhäuser Basel eBooks. 7 indexed citations
9.
Herrling, Paul L.. (2005). The drug discovery process. Birkhäuser Basel eBooks. 62. 1–14. 11 indexed citations
10.
Fischer, Frauke, et al.. (2004). List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases. 1(2-3). 113–152. 11 indexed citations
11.
Herrling, Paul L., et al.. (2004). List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases. 1(6). 269–322. 1 indexed citations
12.
Bum, Elisabeth Ngo, Markus Schmutz, A Rakotonirina, et al.. (2004). Anticonvulsant activity of Mimosa pudica decoction. Fitoterapia. 75(3-4). 309–314. 98 indexed citations
13.
Bum, Elisabeth Ngo, A Rakotonirina, S.V. Rakotonirina, & Paul L. Herrling. (2003). Effects of Cyperus articulatus compared to effects of anticonvulsant compounds on the cortical wedge. Journal of Ethnopharmacology. 87(1). 27–34. 16 indexed citations
14.
Dyer, Mark R. & Paul L. Herrling. (2000). Progress and Potential for Gene-Based Medicines. Molecular Therapy. 1(3). 213–224. 30 indexed citations
15.
Herrling, Paul L.. (1998). Maximizing pharmaceutical research by collaboration. Nature. 392(6679). 32–35. 12 indexed citations
17.
Turski, Lechosław, Thomas Klockgether, Karl‐Heinz Sontag, Paul L. Herrling, & Jeffrey C. Watkins. (1987). Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel antagonist, in rodents. Neuroscience Letters. 73(2). 143–148. 56 indexed citations
19.
Herrling, Paul L. & C.D. Hull. (1980). Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons. Brain Research. 192(2). 441–462. 141 indexed citations
20.
Markstein, R., Paul L. Herrling, H. Asper, & W. Ruch. (1978). THE EFFECT OF BROMOCRIPTINE ON RAT STRIATAL ADENYLATE CYCLASE AND RAT BRAIN MONOAMINE METABOLISM. Journal of Neurochemistry. 31(5). 1163–1172. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026